Document Detail


Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
MedLine Citation:
PMID:  20736855     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
INTRODUCTION: Women with non-small cell lung cancer (NSCLC) are more likely to have better survival than men. This study intended to assess gender differences in the survival of these patients in a large registry population.
METHODS: In 2005, the Japanese Joint Committee for Lung Cancer Registration performed a nationwide retrospective registry study regarding the prognosis and clinicopathologic profiles of patients who underwent resection for primary lung neoplasms in 1999. The registry data of 12,509 patients with NSCLC were analyzed in terms of gender differences in prognosis and clinicopathologic features.
RESULTS: There were 8353 (66.8%) men and 4156 (33.2%) women with a mean age at operation of 66.4 and 65.0 years, respectively (p < 0.001). Women had a higher incidence of adenocarcinoma (p < 0.001) and stage IA disease (p < 0.001) than men. The overall survival was significantly better in women than men. The 5-year survival rates (5-YSRs) for women and men were 75.6 and 57.9%, respectively (p = 0.0000). According to histology, the overall survival of women was significantly better than that of men for both adenocarcinoma (5-YSR, 77.7 versus 61.9%, p = 0.0000) and nonadenocarcinoma (5-YSR, 59.3 versus 53.1%, p = 0.035). In adenocarcinoma, women had a significantly better prognosis than men for pathologic stage I/II disease. However, in nonadenocarcinoma, there was no significant prognostic difference between the two genders in pathologic stage I/II disease.
CONCLUSIONS: Women with NSCLC, especially with an adenocarcinoma histology, had better survival than men. Women were more likely to have adenocarcinoma and stage IA disease, which might account for the better prognosis in women.
Authors:
Hiroyuki Sakurai; Hisao Asamura; Tomoyuki Goya; Kenji Eguchi; Yoichi Nakanishi; Noriyoshi Sawabata; Meinoshin Okumura; Etsuo Miyaoka; Yoshitaka Fujii;
Related Documents :
9316005 - Risk factors for lung cancer among women in poland.
1623745 - Risk factors for reduced pulmonary function in women. a possible relationship between p...
9353675 - Unemployment and cancer: a literature review.
15702235 - Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to copd.
21892335 - The role of corifollitropin alfa in controlled ovarian stimulation for ivf in combinati...
16920525 - Preconceptional health: risks of adverse pregnancy outcomes by reproductive life stage ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer     Volume:  5     ISSN:  1556-1380     ISO Abbreviation:  J Thorac Oncol     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101274235     Medline TA:  J Thorac Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1594-601     Citation Subset:  IM    
Affiliation:
Division of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase I...
Next Document:  A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 3030...